Company Filing History:
Years Active: 1993-2010
Title: Ronald M. Jones: Innovator in Lipid Measurement Technologies
Introduction
Ronald M. Jones, an inventive mind based in Mountain View, CA, has made significant contributions to the field of lipid measurement through his innovative devices and methods. With a total of 10 patents to his name, his work focuses on the critical assessment of cholesterol levels, particularly in the context of high-density lipoproteins (HDL) and low-density lipoproteins (LDL).
Latest Patents
Among his notable inventions are two advanced assay devices. The first is a **High-Density Lipoprotein Assay Device and Method**, which facilitates the precise measurement of HDL-associated cholesterol in blood-fluid samples. This invention cleverly avoids interference from reagents used in the cholesterol quantification process, thereby maintaining the integrity of the assay results. Additionally, it allows for the removal of non-HDL lipoproteins without interrupting the assay. The second device is tailored for the **Direct Measurement of LDL Cholesterol**, where selective precipitation and immunoseparation techniques are utilized to streamline the assay entirely within a flow strip format.
Career Highlights
Ronald M. Jones is affiliated with Cholestech Corporation, a company recognized for its commitment to enhancing health assessment through innovative diagnostic technologies. His work at Cholestech showcases his dedication to making advancements in the field of cholesterol measurement, which plays a crucial role in cardiovascular health.
Collaborations
During his career, Ronald has worked alongside notable colleagues such as Thomas E. Worthy and Anthony Joseph Nugent. Their collaborative efforts have undoubtedly contributed to the success of their projects and advancements in lipid analysis technology.
Conclusion
Through his inventive spirit and dedication to improving cholesterol measurement methods, Ronald M. Jones has established himself as a significant inventor in the healthcare technology sector. His contributions, particularly through his latest patents, continue to impact the way lipid levels are assessed, promoting better health outcomes.